相关实验视频

Updated: Jul 12, 2025

Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood

Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood

Published on: February 1, 2013

推进适应性细胞疗法的前沿:从临床前到临床环境的变革性机制主义之旅

Ashi Mannan¹, Chirag Kakkar¹, Sonia Dhiman¹

¹Chitkara College of Pharmacy, Chitkara University, Rajpura, 140401, Punjab, India.

International immunopharmacology

|October 24, 2023

概括

适应性细胞疗法 (ACT) 通过修改T细胞来增强免疫系统对抗癌症. 本综述涵盖了ACT的进展,从临床前研究到改善癌症治疗的临床应用.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
生物技术是生物技术.

背景情况:

癌症免疫疗法取得了重大进展,特别是针对各种瘤批准的免疫检查点阻塞治疗.
适应性细胞疗法 (ACT) 是另一种有前途的癌症治疗方法,它修改了患者的免疫系统以向瘤细胞.
最近的进展推动了ACT从临床前研究进入临床环境,显示出令人鼓舞的结果.

研究的目的:

审查癌症治疗适应性细胞疗法 (ACT) 的进展.
涵盖ACT从临床前研究到临床应用的进展.
突出ACT在瘤学中的当前状态和未来潜力.

主要方法:

对适应性细胞疗法 (ACT) 的临床前和临床研究的审查.
专注于T细胞受体 (TCR) 和仿制抗原受体 (CAR) 设计的T细胞疗法.
对各种瘤类型的临床试验数据和结果的分析.

主要成果:

适应性细胞疗法 (ACT) 在各种瘤类型中表现出令人鼓舞的结果.
针对向癌症治疗的工程T细胞与TCR或CAR取得了重大进展.
全球正在进行的临床试验旨在进一步提高ACT的疗效和应用.

结论:

适应性细胞疗法 (ACT) 是一个快速发展的领域,在癌症治疗中具有显著的潜力.
持续的研究和临床试验对于优化ACT策略至关重要.
ACT提供了一种强大的方法来利用免疫系统对抗癌症.

关键词:

收养细胞疗法采用细胞疗法.癌症癌症癌症癌症工程T细胞的工程T细胞这些T细胞是T细胞.瘤是一个瘤.

更多相关视频

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

相关概念视频

Preclinical Development: Overview

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.